Psychedelics like LSD, psilocybin, DMT, and MDMA have a reputation for unlocking self-awareness, helping emotional healing, and sometimes opening a window onto spiritual insight.
Nasty (Leonce Remix), by Leonce
from the album Nasty (Leonce Remix)
For those of us who are autistic without knowing it or still working out an unrecognized neurodivergence, though, a trip can amplify things we have long kept hidden. What starts as a search for clarity can turn into sensory overload, runaway overthinking, or a heavy sense of alienation.
That doesn’t have to mean you failed to “break through” or to reach the depths other people describe. Those moments can be signposts, chances to accept a part of yourself that has been masked or misunderstood for years. What matters is seeing how psychedelics can bring autistic traits to the surface.
The research on autistic people who use psychedelics is thin, and it doesn’t show the drugs going badly for most of them. In an online survey published in 2024, 233 autistic adults described their most impactful psychedelic experience. Most credited it with less psychological distress (82%) and less social anxiety (78%), and 70% with more social engagement. A fifth also reported harms such as more anxiety, and some called it one of the most negatively impactful experiences of their lives. The respondents chose to take part, so the survey can’t say how common either outcome is.1
Hard trips aren’t specific to autism either. When 1,993 people described their worst experience on psilocybin mushrooms, 39% ranked it among the five most challenging experiences of their lives.2 The questionnaire researchers built from those accounts scores seven kinds of difficulty: grief, fear, death, insanity, isolation, physical distress and paranoia.3 Overload, alienation and the terror of losing yourself are ordinary bad-trip material. None of them, on its own, points to autism, so at most a hard trip surfaces a pattern to check against the rest of your life.
Sensory Overload
LSD and psilocybin often sharpen the senses: vivid colors, complex patterns, small shifts in perception. Most people experience this as a joyful enrichment of reality. For people with autistic traits, the same shifts can overwhelm or distress.
Imagine walking through a forest on psilocybin. The leaves shimmer and iridesce, the sun sparkles through the trees like cosmic rays, and the forest floor crunches underfoot with surreal intensity. For some, this is magic. But with an autistic sensory system you might not be able to filter any of it. Every rustle, every beam of light, every small change in texture can feel as if it’s bearing down on you at once. Instead of feeling connected to nature, you feel trapped inside it, bombarded by more than your mind can sort.
The useful question comes afterward, sober: did the forest feel familiar? Unusually strong or weak reactions to sensory input are one of the criteria autism is diagnosed on.4 Overload on a high dose is common. The telling kind looks like a louder version of the supermarket, the open-plan office or the family dinner.
Social Disconnection
One of the celebrated effects of psychedelics, MDMA especially, is emotional opening: barriers between people come down and feelings of connection and empathy flood in. Many describe a sense of unity that crosses the line between self and other. With unrecognized autistic traits, that unity can stay just out of reach, as though an invisible wall stands between you and everyone else.
On MDMA, while others feel closer, you might become hyper-aware of the mechanics of social interaction: whether you’re making enough eye contact, whether your face is matching the mood, whether you’re keeping up with the rhythm of the conversation. Instead of being swept up in the euphoria, you feel more isolated, and the drug only sharpens your awareness of how hard socializing is.
That isn’t a fixed effect of MDMA on autistic people. In a small 2018 trial, 12 autistic adults with marked to severe social anxiety had two sessions of MDMA-assisted psychotherapy, eight with MDMA and four with a placebo. A month after the second session, their scores on a social anxiety scale had dropped by 44 points on average with MDMA and 19 with placebo, and the gains mostly held six months later.5 The sessions ran in a clinic, with screening, preparation and therapists in the room. A party has none of that, so the trial says little about how MDMA goes there.
Psychedelics Can Amplify the Mind’s Need for Control
For many, psychedelics bring on a state of flow, a sense of being carried along by thoughts and effortlessly connecting ideas that seemed unrelated. With autistic traits, that free flow can quickly turn into a cascade of overanalysis, the mind clinging to every detail and taking everything apart until it becomes overwhelming.
Say you’re on LSD. The people around you are lost in the beauty of their surroundings or the novelty of their thoughts, and you are stuck in a loop, analyzing the significance of one word someone said or the symbolism of some random object. You might fixate on why the trip isn’t going the way you expected and sink into layer after layer of self-critique and doubt.
Intense focus and analysis are hallmarks of autism, and they can get especially pronounced on psychedelics.
The work is to practice letting go: to notice when you’re gripping the details too tightly, and to find ways to soften that instinct. In that survey, the only change that substantially predicted less distress afterward was greater psychological flexibility, the capacity to loosen that grip.1
Decoding the Abstract
DMT is notorious for vivid, surreal experiences that many users read as full of metaphor. People meet fantastical beings, otherworldly landscapes, or intensely symbolic images that they take to represent spiritual truths or emotional lessons. For people with autistic traits, these experiences can confuse more than they enlighten.
Autistic people often process information more literally, which makes abstract visions hard going. You might see a serpent slithering through a vast cosmic landscape that others describe as a metaphor for transformation or rebirth, while you’re stuck wondering what a serpent has to do with anything, trying to assemble a literal reading that doesn’t fit.
Literalness is a weaker sign than its reputation. Across 41 studies, autistic people on average understood figurative language less well than non-autistic peers, but the difference was small and not significant when the groups were matched on language ability.6 Confusion in front of a serpent says little by itself. A lifetime of other people’s metaphors landing as puzzles says more.
Ego Dissolution and the Fragmented Self
LSD and psilocybin are known for what’s called “ego dissolution” or “ego death”: the sense that the boundary between self and world is melting, leaving a state of unity or oneness. For neurotypical users this can be expansive and freeing, a chance to step outside their usual identity for a while and feel connected to the universe.
For people with unrecognized autism, whose sense of self may already feel fragile or fragmented, the dissolution can be disorienting or terrifying. Rather than feeling liberated, you might feel you’re losing your grip on who you are. If your identity was built through years of masking, constantly adjusting your behavior to fit neurotypical norms, the trip may strip the masks off and leave you exposed, unsure where your real self begins and ends.
It Might Be Autism
Sensory overload, social disconnection, overanalysis, trouble with metaphor and a fragile sense of self all turn up in hard trips generally, so a trip can’t tell you whether you’re autistic. It can hand you a question to take back to ordinary life: whether the forest was the supermarket turned up, the party every office party with the volume on, the loop the same one that keeps you rereading a two-line email for an hour. When the trip looks like your sober days made louder, a clinician who assesses autistic adults can tell you what the pattern means. Recognizing that you might be autistic can explain why you experience things so differently, why you’ve spent so much time masking, and why insights from psychedelics sometimes feel disjointed or alienating. A “better” trip next time is the smaller goal; the larger one is using what you saw to unmask.
Notes
Jack Stroud and colleagues, “Perceived changes in mental health and social engagement attributed to a single psychedelic experience in autistic adults: results from an online survey,” Psychopharmacology 242, no. 2 (2025): 373–387, published online October 2024. Participants were self-selecting and had high Autism Quotient scores; the authors call for caution given the non-experimental design and biased sampling. Europe PMC
Theresa M. Carbonaro and colleagues, “Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences,” Journal of Psychopharmacology 30, no. 12 (2016): 1268–1278. Despite the difficulty, 84% said they had benefited from the experience. PMC
Frederick S. Barrett and colleagues, “The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms,” Journal of Psychopharmacology 30, no. 12 (2016): 1279–1295. PMC
Centers for Disease Control and Prevention, “Clinical Testing and Diagnosis for Autism Spectrum Disorder,” reproducing DSM-5 criterion B4: “Hyper- or hyporeactivity to sensory input or unusual interest in sensory aspects of the environment.” CDC
Alicia L. Danforth and colleagues, “Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study,” Psychopharmacology 235, no. 11 (2018): 3137–3148. Mean Liebowitz Social Anxiety Scale scores fell from 91.8 to 46.4 in the MDMA group and from 83.3 to 64.0 in the placebo group, and stood at 42.9 and 60.0 at six months. PMC